A Randomized Double Blind Phase 1a Clinical Trial of THR-18, a PAI-1 Derived peptide, in Normal Volunteers
Phase of Trial: Phase I
Latest Information Update: 03 Feb 2012
At a glance
- Drugs THR 18 (Primary)
- Indications Myocardial infarction; Stroke; Thrombosis
- Focus Adverse reactions
- 03 Feb 2012 Results published in the World Wide Web [online].
- 07 Sep 2010 Results published in a media release.
- 01 Mar 2010 New trial record